Daniel Alain Acquires Stake in Applied Biology

Nicoya Lifesciences Acquires Applied Photophysics

June 10, 2025

Biotechnology

Nicoya Lifesciences acquired UK-based Applied Photophysics, integrating established biophysical instrumentation (CD, stopped-flow, nanoDSF) with Nicoya's SPR platforms to create a more comprehensive biologics characterization offering. The deal immediately doubles Nicoya's revenue, triples its customer base, establishes Applied Photophysics's Leatherhead site as Nicoya's European hub, and was financed by Nicoya's existing investor syndicate led by Graphite Ventures.

Biotage AB Acquires ATDBio

October 20, 2021

Biotechnology

Swedish life sciences company Biotage AB has acquired UK-based oligonucleotide specialist ATDBio for approximately £45 million in cash and shares. The deal brings ATDBio’s complex DNA/RNA synthesis capabilities and its founders into the Biotage Group to accelerate capability expansion and scale molecular diagnostics, therapeutics and sequencing support services.

IK Partners Acquires Majority Stake in BIOBank

May 29, 2024

Medical Devices

IK Partners (via its IK Small Cap III fund) has agreed to acquire a majority stake in French tissue bank BIOBank from Verto Growth, Capital Croissance and management, who will reinvest. BIOBank, headquartered in Lieusaint, France, is a leading processor and distributor of bone allografts for orthopaedic, spine, dental and cranio‑maxillofacial surgery; IK plans to support market-share gains in France, accelerate international expansion and pursue a buy‑and‑build strategy.

OLAPLEX Acquires Purvala Bioscience

August 26, 2025

Biotechnology

Olaplex Holdings, Inc. has acquired Purvala Bioscience, a Boston-based biotech founded by Dr. Bradley Olsen that develops bioinspired molecules for health and beauty applications. The purchase — Olaplex's first acquisition since launching its brand over ten years ago — is intended to accelerate product innovation by combining Purvala’s molecular technologies with Olaplex’s patent-protected bond-building platform.

Nordstjernan Acquires Finnish Diagnostics Company Aidian from Axcel-managed Funds

February 22, 2022

Medical Devices

Nordstjernan has signed an agreement to acquire Finnish in‑vitro diagnostics company Aidian from funds managed by Nordic private equity firm Axcel. Aidian, headquartered in Espoo, Finland, develops, manufactures and sells point‑of‑care instruments and tests (250+ employees; ~EUR100m sales in 2021); the transaction is expected to close in Q1 2022 and terms were not disclosed.

ICL Acquires Majority of Lavie Bio's Activities and Assets from Evogene

July 8, 2025

Biotechnology

ICL Group Ltd. has completed the acquisition of the majority of activities and assets of Lavie Bio Ltd., Evogene's ag-biologicals subsidiary, including Lavie Bio's BDD technology platform, microbial bank, pipeline and current commercial products. Evogene also transferred its MicroBoost AI tech-engine for agriculture to ICL as part of the divestiture; Lavie Bio core personnel will move to ICL while certain strategic partnerships remain with Lavie Bio.